Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2008 1
2012 1
2014 2
2015 2
2016 1
2017 2
2019 3
2020 3
2021 2
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2.
Szabó E, Modok S, Rónaszéki B, Faragó A, Gémes N, Nagy LI, Hackler L Jr, Farkas K, Neuperger P, Balog JÁ, Balog A, Puskás LG, Szebeni GJ. Szabó E, et al. Front Med (Lausanne). 2023 Jul 17;10:1176168. doi: 10.3389/fmed.2023.1176168. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37529238 Free PMC article.
The transcriptional control of the VEGFA-VEGFR1 (FLT1) axis in alternatively polarized murine and human macrophages.
Domokos A, Varga Z, Jambrovics K, Caballero-Sánchez N, Szabo E, Nagy G, Scholtz B, Halasz L, Varadi E, Bene KP, Mazlo A, Bacsi A, Jeney V, Szebeni GJ, Nagy L, Czimmerer Z. Domokos A, et al. Among authors: szabo e. Front Immunol. 2023 May 4;14:1168635. doi: 10.3389/fimmu.2023.1168635. eCollection 2023. Front Immunol. 2023. PMID: 37215144 Free PMC article.
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.
Szebeni GJ, Gémes N, Honfi D, Szabó E, Neuperger P, Balog JÁ, Nagy LI, Szekanecz Z, Puskás LG, Toldi G, Balog A. Szebeni GJ, et al. Among authors: szabo e. Front Immunol. 2022 Mar 31;13:846248. doi: 10.3389/fimmu.2022.846248. eCollection 2022. Front Immunol. 2022. PMID: 35432314 Free PMC article.
32 results